Turmeric and Curcumin for Arthritis References

  1. Yang Y, Wu X, Wei Z, Dou Y, Zhao D, Wang T, Bian D, Tong B, Xia Y, Xia Y, Dai Y.
  2. Funk JL, Oyarzo JN, Frye JB, Chen G, Lantz RC, Jolad SD, Sólyom AM, Timmermann BN. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J Nat Prod. 2006 Mar;69(3):351-5. PubMed PMID: 16562833; PubMed Central PMCID: PMC2533857.
  3. Nakagawa Y, Mukai S, Yamada S, Matsuoka M, Tarumi E, Hashimoto T, Tamura C, Imaizumi A, Nishihira J, Nakamura T. Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study. J Orthop Sci. 2014 Nov;19(6):933-9. doi: 10.1007/s00776-014-0633-0. Epub 2014 Oct 13. PubMed PMID: 25308211; PubMed Central PMCID: PMC4244558.
  4. G. Huang, Z. Xu, Y. Huang, X. Duan, W. Gong, Y. Zhang, et al. Curcumin protects against collagen-induced arthritis via suppression of BAFF production. J. Clin. Immunol., 33 (3) (2013), pp. 550–557
  5. Henrotin Y, Priem F, Mobasheri A. Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management. SpringerPlus. 2013;2:56. doi:10.1186/2193-1801-2-56.
  6. Y. Henrotin, M. Gharbi, Y. Dierckxsens, F. Priem, M. Marty, L. Seidel, A. Albert, E. Heuse, V. Bonnet, C. Castermans. Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial. BMC Complement. Altern. Med., 14 (2014), p. 159.
  7. Panahi, A.R. Rahimnia, M. Sharafi, G. Alishiri, A. Saburi, A. Sahebkar. Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytother. Res., 28 (11) (2014), pp. 1625–1631.
  8. Prasad S, Aggarwal BB. Turmeric, the Golden Spice: From Traditional Medicine to Modern Medicine. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. Boca Raton (FL): CRC Press; 2011. Chapter 13. Available from: http://www.ncbi.nlm.nih.gov/books/NBK92752/
  9. Tayyem RF, Heath DD, Al-Delaimy WK, Rock CL. Curcumin content of turmeric and curry powders. Nutr Cancer. 2006;55(2):126-31. PubMed PMID: 17044766.
  10. Kwon HL, Chung MS. Pilot-scale subcritical solvent extraction of curcuminoids from Curcuma long L. Food Chem. 2015 Oct 15;185:58-64. doi: 10.1016/j.foodchem.2015.03.114. Epub 2015 Apr 2. PubMed PMID: 25952841.
  11. Yang W, Fu J, Yu M, Wang D, Rong Y, Yao P, Nüssler AK, Yan H, Liu L. Effects of three kinds of curcuminoids on anti-oxidative system and membrane deformation of human peripheral blood erythrocytes in high glucose levels. Cell Physiol Biochem. 2015;35(2):789-802. doi: 10.1159/000369738. Epub 2015 Jan 30. PubMed PMID: 25634758.
  12. Neyrinck AM, Alligier M, Memvanga PB, Névraumont E, Larondelle Y, Préat V, Cani PD, Delzenne NM. Curcuma longa extract associated with white pepper lessens high fat diet-induced inflammation in subcutaneous adipose tissue. PLoS One. 2013 Nov 19;8(11):e81252. doi: 10.1371/journal.pone.0081252. eCollection 2013. PubMed PMID: 24260564; PubMed Central PMCID: PMC3834320.
  13. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998 May;64(4):353-6. PubMed PMID: 9619120.
  14. Suresh D, Srinivasan K. Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats. Indian J Med Res. 2010 May;131:682-91. PubMed PMID: 20516541.
  15. Aggarwal BB, Gupta SC, Sung B. Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. British Journal of Pharmacology. 2013;169(8):1672-1692. doi:10.1111/bph.12131.
  16. González-Rivera, TC. Anti-TNF Medications. MD American College of Rheumatology. https://www.rheumatology.org/Practice/Clinical/Patients/Medications/Anti-TNF/ Last updated June 2012. Accessed July 14, 2015.
  17. Goel A, Boland CR, Chauhan DP. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett. 2001 Oct 30;172(2):111-8. PubMed PMID: 11566484.
  18. Aggarwal BB, Harikumar KB. Potential Therapeutic Effects of Curcumin, the Anti-inflammatory Agent, Against Neurodegenerative, Cardiovascular, Pulmonary, Metabolic, Autoimmune and Neoplastic Diseases. The international journal of biochemistry & cell biology. 2009;41(1):40-59. doi:10.1016/j.biocel.2008.06.010.
  19. Rao CV. Regulation of COX and LOX by curcumin. Adv Exp Med Biol. 2007;595:213-26. Review. PubMed PMID: 17569213.
  20. Zhang Y, Shi S, Chen X, Peng M. Functionalized magnetic nanoparticles coupled with mass spectrometry for screening and identification of cyclooxygenase-1 inhibitors from natural products. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jun 1;960:126-32. doi: 10.1016/j.jchromb.2014.04.032. Epub 2014 Apr 26. PubMed PMID: 24793085.
  21. Drobnic F, Riera J, Appendino G, et al. Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial. Journal of the International Society of Sports Nutrition. 2014;11:31. doi:10.1186/1550-2783-11-31.
  22. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807–818. doi: 10.1021/mp700113r.
  23. Burgos-Morón E, Calderón-Montaño JM, Salvador J, Robles A, López-Lázaro M. The dark side of curcumin. Int J Cancer. 2010 Apr 1;126(7):1771-5. doi: 10.1002/ijc.24967. PubMed PMID: 19830693.
  24. Steven D. Ehrlich, NMD. Tumeric. University of Maryland Medical Center. http://umm.edu/health/medical/altmed/herb/turmeric Last reviewed on 6/26/2014. Accessed July 11, 2015.
  25. Ghosh S, Banerjee S, Sil PC. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. Food Chem Toxicol. 2015 Jun 9. pii: S0278-6915(15)00187-8. doi: 10.1016/j.fct.2015.05.022. [Epub ahead of print] Review. PubMed PMID: 26066364.